Founded in 1987, AMS Biotechnology is regarded today as a leading company adding to the acceleration of discovery through the provision of cutting-edge life research technology products and services for research and development in the medical, nutrition, energy and cosmetics industries. The AMSBIO range includes expert antibodies, peptides and recombinant proteins. In addition the company can draw upon in-depth experience in extracellular matrices to supply elegant solutions for learning cell motility, migration, invasion and proliferation.Every American must have gain access to to high-quality, safe and suitable health care, and we have to increase our attempts to achieve that objective because our slow improvement is not appropriate, stated AHRQ Director Carolyn M. Clancy, M.D. These AHRQ 2010 State Snapshots not merely provide claims with a benchmark on what they are carrying out in these areas, but they provide resources that claims can use to make improvements also. Related StoriesDiabetes drug liraglutide ineffective in individuals with advanced heart failureHeart attack patients diagnosed and treated for diabetes experience improved cardiac outcomesNew Cleveland Clinic research shows bariatric medical procedures is safe choice for managing type 2 diabetes in over weight or mildly obese patientsThe 2010 State Snapshots, an interactive Web-based tool, show whether a continuing state provides improved or worsened on specific healthcare quality measures.